Posted 12 February, 2024
Metagenomi, Inc. IPO completed
IPO completed detected for ticker Nasdaq:MGX in a 424B4 filed on 12 February, 2024.
This is an initial public offering of shares of common stock of Metagenomi, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Metagenomi, Inc.
Health Care/Life Sciences • Biotechnology
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editing toolbox, therapeutic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.Market Cap
$73.0M
View Company Details
$73.0M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.